The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Zacks Investment Research on MSN
Adaptive Biotechnologies (ADPT) moves 9.7% higher: Will this strength last?
Adaptive Biotechnologies (ADPT) shares rallied 9.7% in the last trading session to close at $18.73. This move can be attributable to notable volume with a higher number of shares being traded than in ...
SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics ...
Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Third Quarter Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being ...
Adaptive Biotechnologies’ Q1 2026 revenue was $70.9 million, a 45% year-over-year increase. The MRD segment contributed $67.1 million, up 53% year-over-year. The company ended Q1 with a cash position ...
Uncertainty is a non-ideal but inevitable part of the financial sector—especially concerning financial planning and analysis. The hard reality is that perfect financial decisions rarely exist, and ...
SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results